Spinal Singularity develops the Connected Catheter™, a fully internal, extended-use catheter system for adult males with chronic Lower Urinary Tract Dysfunction that may remain in the body up to 29 days and could replace as many as 200 disposable intermittent catheters. The company is based in San Clemente, CA and was founded in 2015 by Derek Herrera; its leadership includes CEO William ‘Bill’ Colone, Director of R&D Jeff Kasalko, Director of Quality Stephanie Rallis, and Director of US Sales Shannon Metzger. It closed a $3.1M equity seed round to fund clinical validation of the Connected Catheter™ and has also earned over $500k in non-dilutive funding from sources including the NIH, NSF, IndieGoGo, the PrimeUC Competition and UCLA Business Plan Competitions. Spinal Singularity anticipates commencing First-in-Man clinical testing in 2017 and intends to pursue CE Mark approval and FDA clearance in 2018. The company is using the new funding specifically to support clinical validation efforts.

Total raised

$3M

Funding rounds

1

Latest round

Seed

Latest activity

Oct 2017